The UC Cancer Institute offers the only multidisciplinary team approach to treatment of sarcoma in the Tristate.
Sarcoma is a rare type of cancer that develops from certain tissues, like bone or muscle. There are two main types of sarcoma: bone sarcomas and soft tissue sarcomas. Soft tissue sarcomas can develop from soft tissues like fat, muscle, nerves, fibrous tissues, blood vessels or deep skin tissues and can be found in any part of the body.
The National Comprehensive Cancer Network recommends the involvement of a multidisciplinary team when treating sarcoma.
Patients within the UC Cancer Institute’s sarcoma program will receive this team approach to care, including expertise of medical oncologists, surgeons, radiation oncologists, pathologists, orthopaedic physicians, pathologists, plastic surgeons, rehabilitation physicians and physical and occupational therapists, who interact and collaborate for tailored treatments and best outcomes.
Cancer specialists in this program offer the best advanced therapies, including brachytherapy, which involves the use of radioactive seeds planted in a tumor to reduce the patient’s exposure to radiation, in addition to experimental treatments through the Phase I Clinical Trials Program and advanced limb reconstruction and preservation techniques.
These experienced physicians, who include fellowship-trained medical oncologists, surgeons, radiation oncologists and more, meet regularly during a dedicated sarcoma tumor board to review and plan individualized treatments. They also work together to provide the latest therapies for common and rare skin cancers but also offer the latest, innovative treatments through the clinical trials program.
These teams, with their combined expertise and knowledge, are working together to individualize treatments for the best results.